ONC Competitors & Alternatives
Compare BeiGene, Ltd. with similar stocks in the same industry
Biotechnology
ONC
Main Stock$382.27
Tradestie Score
39
Market Cap
$36.81B
P/E Ratio
68.8
Revenue Growth
0.3%
Analyst Upside
+14.2%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
REGN
Regeneron Pharmaceuticals Inc
|
$819.09
|
$63.59B | 19.9 | 44 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$227.28
|
$60.38B | 38.0 | 50 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$875.76
|
$46.96B | 33.9 | 52 | Compare |
|
INSM
Insmed, Inc.
|
$95.06
|
$31.13B | - | 52 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$89.67
|
$24.57B | - | 63 | Compare |
|
GMAB
Genmab A/S ADS
|
$40.00
|
$19.56B | 31.2 | 37 | Compare |
|
INCY
Incyte Genomics Inc
|
$116.93
|
$16.93B | 14.5 | 77 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$63.75
|
$15.70B | 33.1 | 44 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.55
|
$15.22B | - | 50 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$242.99
|
$12.36B | 18.3 | 51 | Compare |
More ONC Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry